Vigilare Wealth Management’s ProShares Short QQQ PSQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$811K Sell
32,345
-20,995
-39% -$571K 0.25% 52
2026
Q1
$1.72M Buy
+53,340
New +$1.64M 0.58% 32
2025
Q2
Sell
-61,587
Closed -$2.5M 128
2025
Q1
$2.5M Buy
61,587
+41,840
+212% +$1.58M 1% 20
2024
Q4
$739K Sell
19,747
-64,285
-77% -$2.46M 0.3% 34
2024
Q3
$3.31M Buy
+84,032
New +$3.46M 1.34% 13
2024
Q2
Sell
-33,154
Closed -$1.45M 95
2024
Q1
$1.45M Buy
33,154
+10,551
+47% +$481K 0.72% 24
2023
Q4
$1.07M Sell
22,603
-25,993
-53% -$1.35M 0.55% 31
2023
Q3
$2.65M Sell
48,596
-15,093
-24% -$799K 1.69% 13
2023
Q2
$3.37M Buy
63,689
+51,728
+432% +$3.03M 1.94% 10
2023
Q1
$728K Buy
+11,961
New +$797K 0.41% 31
2020
Q4
Sell
-6,000
Closed -$496K 156
2020
Q3
$496K Buy
+6,000
New +$516K 0.52% 54

Other funds holding PSQ

Vigilare Wealth Management's PSQ Position: Q2 2026 in Review

Vigilare Wealth Management reduced its ProShares Short QQQ (PSQ) stake by 39% in Q2 2026, selling an estimated $571K and leaving 32,345 shares worth $811K. The position accounts for 0.25% of the portfolio, ranked #52.

Vigilare Wealth Management first reported a position in PSQ in Q3 2020 and has held it in 11 quarters since. The position peaked at $3.37M in Q2 2023. 13 funds tracked by Wall St. Rank hold PSQ as of Q2 2026.

  • Vigilare Wealth Management held 32,345 shares of ProShares Short QQQ worth $811K as of Q2 2026.
  • Vigilare Wealth Management sold 20,995 ProShares Short QQQ shares in Q2 2026, an estimated $571K.
  • ProShares Short QQQ made up 0.25% of Vigilare Wealth Management's portfolio in Q2 2026, its #52 holding.
  • Vigilare Wealth Management first reported a position in ProShares Short QQQ in Q3 2020 and has held it in 11 quarters since.
  • Vigilare Wealth Management's ProShares Short QQQ position peaked at $3.37M in Q2 2023.
  • 13 funds tracked by Wall St. Rank held ProShares Short QQQ as of Q2 2026.

Based on Vigilare Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.